X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ophthalmology (544) 544
index medicus (533) 533
humans (452) 452
macular degeneration (386) 386
aged (287) 287
female (277) 277
male (275) 275
ranibizumab (246) 246
neovascular age-related macular degeneration (206) 206
aged, 80 and over (192) 192
middle aged (190) 190
age-related macular degeneration (182) 182
bevacizumab (157) 157
vascular endothelial growth factor (147) 147
eye diseases (142) 142
endothelial growth-factor (139) 139
fluorescein angiography (133) 133
vascular endothelial growth factor a - antagonists & inhibitors (131) 131
intravitreal injections (127) 127
genetic structures (125) 125
visual acuity (123) 123
physiological aspects (119) 119
angiogenesis inhibitors - therapeutic use (113) 113
choroidal neovascular membranes (112) 112
sense organs (112) 112
choroidal neovascularization (107) 107
retrospective studies (105) 105
neovascular amd (100) 100
tomography, optical coherence (100) 100
retina (98) 98
photodynamic therapy (97) 97
follow-up studies (94) 94
treatment outcome (93) 93
age (89) 89
wet macular degeneration - drug therapy (86) 86
choroidal neovascular membrane (85) 85
care and treatment (82) 82
medicine & public health (82) 82
degeneration (78) 78
macular degeneration - drug therapy (78) 78
visual acuity - physiology (74) 74
choroidal neovascularization - drug therapy (71) 71
neovascularization (70) 70
optical coherence tomography (69) 69
animals (67) 67
therapy (67) 67
wet macular degeneration - diagnosis (67) 67
angiogenesis inhibitors - administration & dosage (66) 66
eye (66) 66
angiogenesis (65) 65
neovascular membranes (65) 65
diabetic retinopathy (63) 63
analysis (61) 61
prospective studies (61) 61
aflibercept (60) 60
macular degeneration - complications (60) 60
vegf (58) 58
amd (57) 57
patients (56) 56
retinal-pigment epithelium (56) 56
verteporfin (56) 56
macular degeneration - pathology (55) 55
anti-vegf (53) 53
antibodies, monoclonal, humanized (51) 51
choroidal neovascularization - etiology (51) 51
fundus oculi (49) 49
adult (47) 47
maculopathy (47) 47
polypoidal choroidal vasculopathy (47) 47
antibodies, monoclonal, humanized - therapeutic use (46) 46
choroidal neovascularization - pathology (46) 46
research (46) 46
endothelial growth factors (45) 45
wet macular degeneration - physiopathology (45) 45
expression (44) 44
macular degeneration - diagnosis (44) 44
choroidal neovascularization - diagnosis (42) 42
photochemotherapy (42) 42
choroid - blood supply (41) 41
prevalence (41) 41
macular degeneration - physiopathology (40) 40
neovascular (40) 40
intravitreal bevacizumab (39) 39
intravitreal ranibizumab (38) 38
medical imaging (38) 38
anti-vascular endothelial growth factor (37) 37
geographic atrophy (37) 37
retinal pigment epithelium (37) 37
surgery (37) 37
studies (36) 36
injection (35) 35
medicine, research & experimental (35) 35
safety (35) 35
risk factors (34) 34
choroidal neovascularization - physiopathology (32) 32
disease (32) 32
macular degeneration - surgery (32) 32
acuity (30) 30
cells, cultured (30) 30
drug therapy (30) 30
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (694) 694
German (31) 31
French (11) 11
Spanish (8) 8
Korean (6) 6
Russian (4) 4
Turkish (3) 3
Portuguese (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Investigative ophthalmology & visual science, ISSN 0146-0404, 2013, Volume 54, Issue 5, pp. 3738 - 3750
Journal Article
Experimental Eye Research, ISSN 0014-4835, 03/2018, Volume 168, pp. 2 - 11
Neovascular age-related macular degeneration (AMD) is a leading cause of vision loss worldwide. Although intravitreal injection of anti-VEGF antibodies and... 
Angiogenesis | Neovascular AMD | Choroidal neovascularization | LC/MS/MS | Retina | Lenvatinib | tyrosine kinase inhibitor | ANGIOGENESIS | VEGF | MACULAR DEGENERATION | COMBINATION | PHASE 1B | Angiogenesis tyrosine kinase inhibitor | E7080 | OPHTHALMOLOGY | OUTCOMES | CARCINOMA | Index Medicus
Journal Article
Journal Article
Investigative Ophthalmology and Visual Science, ISSN 0146-0404, 2014, Volume 55, Issue 1, pp. 337 - 344
Journal Article
Current Ophthalmology Reports, ISSN 2167-4868, 3/2015, Volume 3, Issue 1, pp. 40 - 50
Neovascular age-related macular degeneration (AMD) has a complex pathophysiology, and although anti-VEGF therapy has been one of the most significant and... 
Radiation | Epimacular brachytherapy | Macular degeneration | Intravitreal therapy | Ionizing radiation | Medicine & Public Health | Neovascular age-related macular degeneration | Vitrectomy | Brachytherapy | Ophthalmology | Vascular endothelial growth factor | Combined therapy | Stereotactic radiotherapy
Journal Article
Journal Article
Asia-Pacific Journal of Ophthalmology, 11/2017, Volume 6, Issue 6, pp. 481 - 487
To evaluate the effect of aflibercept on anatomic and visual outcomes in patients with choroidal neovascularization (CNV) previously treated with intravitreal... 
Aflibercept | Neovascular age-related macular degeneration | Ranibizumab
Journal Article
JOURNAL FRANCAIS D OPHTALMOLOGIE, ISSN 0181-5512, 03/2016, Volume 39, Issue 3, pp. 248 - 254
Journal Article
OPHTHALMOLOGE, ISSN 0941-293X, 06/2019, Volume 116, Issue 6, pp. 553 - 562
ZusammenfassungFragestellungReal-Life-Daten ermoglichen einen Einblick in die Versorgungsrealitat von Patienten unter alltaglichen Bedingungen. Die... 
Intravitreal injection | IMPLEMENTATION | Electronic patient record | RECORD SYSTEM | NEOVASCULAR AMD | THERAPY | AMD | OPHTHALMOLOGY | Real life data | EXPERIENCE | SUSTAINED BENEFITS | RANIBIZUMAB | INTRAVITREAL AFLIBERCEPT | Vein occlusion | 12-MONTH OUTCOMES
Journal Article
Translational Vision Science and Technology, ISSN 2164-2591, 03/2019, Volume 8, Issue 2, p. 8
Purpose: We systematically compare the intermodality and interreader agreement in age-related macular degeneration(AMD)-associated neovascularization... 
AMD | Neovascular | Neovascularization | OCTA | neovascular | TYPE-2 NEOVASCULARIZATION | SPECTRAL-DOMAIN | neovascularization | OPHTHALMOLOGY | MACULAR DEGENERATION | COHERENCE TOMOGRAPHY ANGIOGRAPHY | SUBRETINAL HYPERREFLECTIVE MATERIAL | CHOROIDAL NEOVASCULARIZATION | QUANTITATIVE-ANALYSIS
Journal Article
Retina, ISSN 0275-004X, 04/2009, Volume 29, Issue 4, pp. 523 - 529
Purpose: To evaluate the concentration of various cytokines in the aqueous humor of patients with naive, recurrent, and regressed choroidal neovascularization... 
Interleukin-2 | Age-related macular degeneration | Aqueous humor | Tumor necrosis factor-α | Interleukin-8 | Vascular endothelial growth factor | Bevacizumab | Interleukin-6 | C-REACTIVE PROTEIN | interleukin-2 | MACULAR DEGENERATION | NECROSIS-FACTOR-ALPHA | RETINAL VEIN OCCLUSION | aqueous humor | interleukin-8 | CHOROIDAL NEOVASCULAR MEMBRANES | interleukin-6 | tumor necrosis factor-alpha | PROLIFERATIVE DIABETIC-RETINOPATHY | vascular endothelial growth factor | bevacizumab | OPHTHALMOLOGY | INTRAVITREAL BEVACIZUMAB | VITREOUS LEVELS | age-related macular degeneration | ENDOTHELIAL GROWTH-FACTOR | Tumor Necrosis Factor-alpha - metabolism | Recurrence | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Choroidal Neovascularization - etiology | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Macular Degeneration - drug therapy | Aqueous Humor - metabolism | Antibodies, Monoclonal, Humanized | Osmolar Concentration | Angiogenesis Inhibitors - therapeutic use | Female | Interleukin-8 - metabolism | Interleukin-6 - metabolism | Interleukin-2 - metabolism | Cytokines - metabolism | Macular Degeneration - complications | Choroidal Neovascularization - prevention & control | Choroidal Neovascularization - physiopathology | Macular Degeneration - metabolism | Choroidal Neovascularization - metabolism | Aged | Index Medicus
Journal Article
Current Ophthalmology Reports, ISSN 2167-4868, 3/2013, Volume 1, Issue 1, pp. 12 - 19
Age-related macular degeneration (AMD) affects more than 7 million individuals in the USA, making it the most common cause of visual impairment among adults... 
Combination treatment | Neovascular AMD | Medicine & Public Health | Radiation | Anti-VEGF | Treatment paradigms | PEDF inhibitors | Ophthalmology | Triple therapy
Journal Article
European Journal of Ophthalmology, ISSN 1120-6721, 06/2014, Volume 24, Issue 6, pp. 925 - 931
Purpose: To evaluate the efficacy and safety of pars plana vitrectomy (PPV) with subretinal injection of tissue plasminogen activator (tPA) for the treatment... 
Visual acuity | Pars plana vitrectomy | Submacular hemorrhage | Age-related macular degeneration | Tissue plasminogen activator | Counting fingers | SURGERY | VISUAL-ACUITY | MANAGEMENT | MACULAR DEGENERATION | CHOROIDAL NEOVASCULAR LESIONS | NATURAL-HISTORY | GAS | OPHTHALMOLOGY
Journal Article